Geneos Wealth Management Inc. lessened its holdings in HCA Healthcare, Inc. (NYSE:HCA – Free Report) by 78.5% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 861 shares of the company’s stock after selling 3,136 shares during the quarter. Geneos Wealth Management Inc.’s holdings in HCA Healthcare were worth $367,000 at the end of the most recent reporting period.
Other large investors have also recently modified their holdings of the company. Park Place Capital Corp raised its holdings in HCA Healthcare by 2,336.0% during the 2nd quarter. Park Place Capital Corp now owns 1,218 shares of the company’s stock worth $474,000 after purchasing an additional 1,168 shares during the last quarter. Swiss National Bank lifted its holdings in HCA Healthcare by 4.3% in the second quarter. Swiss National Bank now owns 558,900 shares of the company’s stock valued at $214,115,000 after buying an additional 23,100 shares during the period. Cherokee Insurance Co acquired a new stake in HCA Healthcare during the 2nd quarter worth about $3,869,000. Harrell Investment Partners LLC boosted its position in shares of HCA Healthcare by 176.3% during the 2nd quarter. Harrell Investment Partners LLC now owns 1,815 shares of the company’s stock valued at $695,000 after purchasing an additional 1,158 shares in the last quarter. Finally, VIRGINIA RETIREMENT SYSTEMS ET Al lifted its stake in HCA Healthcare by 4.2% in the third quarter. VIRGINIA RETIREMENT SYSTEMS ET Al now owns 297,300 shares of the company’s stock valued at $126,709,000 after buying an additional 11,900 shares during the period. Institutional investors own 62.73% of the company’s stock.
HCA Healthcare Trading Down 1.4%
NYSE HCA opened at $472.40 on Friday. The firm has a market capitalization of $107.80 billion, a P/E ratio of 18.26, a PEG ratio of 1.30 and a beta of 1.36. The business has a fifty day simple moving average of $479.87 and a 200 day simple moving average of $427.38. HCA Healthcare, Inc. has a 12 month low of $295.00 and a 12 month high of $520.00.
HCA Healthcare Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Monday, December 29th. Investors of record on Monday, December 15th were issued a dividend of $0.72 per share. This represents a $2.88 dividend on an annualized basis and a yield of 0.6%. The ex-dividend date was Monday, December 15th. HCA Healthcare’s dividend payout ratio (DPR) is 11.13%.
More HCA Healthcare News
Here are the key news stories impacting HCA Healthcare this week:
- Positive Sentiment: HCA is among the first health systems to access OpenAI’s new healthcare programs — a move that could drive clinical efficiency, faster workflow automation and potential cost savings if deployed broadly across HCA’s network. HCA Healthcare among first to access OpenAI’s new health care programs
- Positive Sentiment: OpenAI launched ChatGPT for Healthcare at several large systems — broader industry adoption reduces implementation risk and can accelerate HCA’s rollout benefits (clinical decision support, patient triage, revenue-cycle automation). OpenAI launches ChatGPT for Healthcare at several large health systems
- Positive Sentiment: HCA and AdventHealth are expanding ER footprints in Florida — inorganic/greenfield capacity additions should help volume growth and market share in a high-margin service line. HCA, AdventHealth expand Florida ER footprints
- Positive Sentiment: A new emergency facility opened in Arlington — incremental capacity and local access that can lift admissions and outpatient revenues. New emergency health facility opens in Arlington
- Positive Sentiment: HCA Florida Capital Hospital and UCF launched a medical residency program — strengthens physician pipeline and could reduce staffing pressures/costs over time. HCA Florida Capital Hospital, UCF create new medical residency program
- Positive Sentiment: An analyst raised HCA’s price target to $520 — a bullish signal that supports upside in the medium term if execution and margins track. HCA Healthcare (NYSE:HCA) Price Target Raised to $520.00
- Neutral Sentiment: HCA Georgia hospital named a new CFO — routine executive hire that supports local operations but is not material company‑wide. HCA Georgia hospital taps CFO
- Neutral Sentiment: HCA rolled out a “Talk to a nurse for free” service — positive PR and access initiative but limited immediate financial impact. HCA says: ‘Talk to a nurse for free’
- Negative Sentiment: CEO exit after nine months at an HCA Virginia behavioral health hospital — leadership turnover can signal integration or operational issues in a growing behavioral-health segment. HCA Virginia behavioral health hospital CEO exits after 9 months
- Negative Sentiment: A MarketWatch note flagged HCA’s relative underperformance versus peers on a recent trading day — highlights near‑term downside risk if investors rotate into other healthcare names. HCA Healthcare Inc. stock underperforms Thursday when compared to competitors despite daily gains
Insider Activity
In related news, EVP Michael R. Mcalevey sold 3,892 shares of the business’s stock in a transaction dated Wednesday, November 5th. The shares were sold at an average price of $473.79, for a total value of $1,843,990.68. Following the transaction, the executive vice president directly owned 3,487 shares of the company’s stock, valued at approximately $1,652,105.73. The trade was a 52.74% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 1.30% of the stock is currently owned by corporate insiders.
Wall Street Analysts Forecast Growth
A number of research analysts recently issued reports on HCA shares. Jefferies Financial Group boosted their target price on shares of HCA Healthcare from $485.00 to $525.00 and gave the company a “buy” rating in a research report on Tuesday, October 28th. Weiss Ratings restated a “buy (b)” rating on shares of HCA Healthcare in a research note on Monday, December 29th. Morgan Stanley cut HCA Healthcare from an “equal weight” rating to an “underweight” rating and set a $425.00 price objective for the company. in a research note on Monday, December 15th. Wells Fargo & Company increased their target price on HCA Healthcare from $431.00 to $452.00 and gave the stock an “equal weight” rating in a report on Wednesday. Finally, Cantor Fitzgerald restated an “overweight” rating on shares of HCA Healthcare in a research note on Monday, October 27th. Fourteen equities research analysts have rated the stock with a Buy rating, nine have given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $485.95.
View Our Latest Report on HCA Healthcare
About HCA Healthcare
HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.
The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.
Recommended Stories
- Five stocks we like better than HCA Healthcare
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- A U.S. “birthright” claim worth trillions – activated quietly
- Ticker Revealed: Pre-IPO Access to “Next Elon Musk” Company
- First Time Since 2007: All Warnings Active
- How the Rich Retire
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA – Free Report).
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
